As the global equity markets struggled to churn out gains in 2011, the opportunities for short-sellers to cash in on the adversity were plentiful. Now as investors turn the page to a new year, there is likely to be a slew of additional opportunities as the markets remain in a volatile state. On the flip side, stocks that have already piqued the interest of short-sellers may present attractive buying opportunities given the potential for a short squeeze. Here are four heavily shorted stocks that could climb higher in the not-too-distant future.

Investopedia Markets: Explore the best one-stop source for financial news, quotes and insights.

A Run on REITs
Short-sellers have homed in on anything and everything related to real estate since the credit crisis in 2008. Recently, they have taken aim at REITs. I believe a couple of these stocks that have been bet against may have the potential to send short-sellers scrambling for the exits in 2012. (For related reading, see How To Analyze Real Estate Investment Trusts.)

AvalonBay Communities (NYSE:AVB) has about 9.2 million shares short, which represents close to 12% of its float. After the company's Q3, AvalonBay did reduce its full-year FFO outlook and issue Q4 guidance below analysts' estimates, but it still remains on solid footing. The apartment REIT will post a 14.8% year-over-year increase in FFO for 2011 if it hits its revised mark.

Another REIT that has been drawing the attention of short-sellers is Boston Properties (NYSE:BXP). There are about 10.3 million shares short of BXP equating to 7.4% of its float. The company also announced Q4 and FY 2012 outlooks for its FFO that were below Wall Street estimates. However, Boston Properties has since increased its quarterly dividend by 10% and shares of BXP are now yielding 2.2%.

Bailing on Biotech
Two names in the biotech space that have been heavily shorted and have the potential to generate a short squeeze are United Therapeutics (Nasdaq:UTHR) and Cubist Pharmaceuticals (Nasdaq:CBST). There are approximately 9.7 million shares short of UTHR amounting to 22.8% of its float. For Cubist, there are about 10.1 million shares short or 27.6% of its float.

Shorts have been getting punished on UTHR as it has surged 13.4% over the course of the past month. The outlook for long investors got brighter on December 27,when France approved the use of United Therapeutics' treatment for pulmonary arterial hypertension. Another bullish indicator for the stock is recent insider buying activity by the company's CEO Martine Rothblatt.

Shares of Cubist continue to trade near a 52-week high as the company prepares to end the year on a couple of high notes. On December 13, Cubist announced the start of a phase 3 trial of a drug aimed at treating patients with intra-abdominal infections. Earlier in the month, the company completed its acquisition of Adolor Corporation, which will augment the Cubist drug portfolio. (Strategic acquisition is becoming a part of doing business. For more, see Key Players In Mergers And Acquisitions.)

The Bottom Line
Buying stocks that are heavily shorted can be risky business. The short activity can make for a rocky ride, but long investors can decrease their risk by buying into companies that have strong fundamentals or a favorable outlook for their business. Only time will tell as to how short-sellers will fare against these four stocks, but in the meantime, I believe it may be worthwhile for investors to begin to do their homework on taking a position on the other side of this trade.

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

At the time of writing, Billy Fisher did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Personal Finance

    A Day in the Life of an Equity Research Analyst

    What does an equity research analyst do on an everyday basis?
  2. Mutual Funds & ETFs

    ETF Analysis: PowerShares S&P 500 Downside Hedged

    Find out about the PowerShares S&P 500 Downside Hedged ETF, and learn detailed information about characteristics, suitability and recommendations of it.
  3. Mutual Funds & ETFs

    ETF Analysis: ProShares Large Cap Core Plus

    Learn information about the ProShares Large Cap Core Plus ETF, and explore detailed analysis of its characteristics, suitability and recommendations.
  4. Mutual Funds & ETFs

    ETF Analysis: iShares Core Growth Allocation

    Find out about the iShares Core Growth Allocation Fund, and learn detailed information about its characteristics, suitability and recommendations.
  5. Mutual Funds & ETFs

    ETF Analysis: iShares MSCI USA Minimum Volatility

    Learn about the iShares MSCI USA Minimum Volatility exchange-traded fund, which invests in low-volatility equities traded on the U.S. stock market.
  6. Stock Analysis

    Should You Follow Millionaires into This Sector?

    Millionaire investors—and those who follow them—should take another look at the current economic situation before making any more investment decisions.
  7. Professionals

    What to do During a Market Correction

    The market has what? Here's what you should consider rather than panicking.
  8. Stock Analysis

    Investors Need to Stop Shorting GoPro. Here's Why

    Discover why investors should stop shorting GoPro. GoPro has been one of the fastest-growing companies since 2005 with many betting against more growth.
  9. Chart Advisor

    Stocks to Short...When the Dust Settles

    Four short trades to consider, but not quite yet. Let the dust settle and wait for a pullback to resistance for a higher probability trade.
  10. Mutual Funds & ETFs

    ETF Analysis: Vanguard Mid-Cap Value

    Take an in-depth look at the Vanguard Mid-Cap Value ETF, one of the largest and most popular mid-cap funds in the U.S. equity space.
  1. Equity

    The value of an asset less the value of all liabilities on that ...
  2. Bear Closing

    Purchasing a security, currency, or commodity in order to close ...
  3. Crowded Short

    A trade on the short side with an overwhelmingly large number ...
  4. Gross Exposure

    The absolute level of a fund's investments.
  5. Hard-To-Sell Asset

    An asset that is extremely difficult to dispose of either due ...
  6. Sucker Yield

    When an investor has essentially risked all of his capital for ...
  1. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  2. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  3. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  4. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  5. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
  6. What happens to the shares of stock purchased in a tender offer?

    The shares of stock purchased in a tender offer become the property of the purchaser. From that point forward, the purchaser, ... Read Full Answer >>

You May Also Like

Trading Center

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!